Leiner
This article was originally published in The Tan Sheet
Executive Summary
Private labeler to begin shipping generic famotidine 10 mg, marketed under ANDA approval granted to Dr. Reddy's Labs, by Oct. 1. Dr. Reddy's ANDA 75-758 for J&J/Merck Pepcid AC equivalent received FDA clearance Aug. 17; Leiner currently markets generic ranitidine 75 mg (Pfizer/Warner-Lambert's Zantac 75) for Dr. Reddy's. Leiner joins Perrigo (marketing under a license from Teva) and Ivax in OTC generic famotidine market (1"The Tan Sheet" Aug. 6, In Brief)
You may also be interested in...
Dr. Reddy’s, Leiner Partnership Focusing On Switches
Dr. Reddy's Laboratories and Leiner Health Products are actively looking at potential Rx-to-OTC switch projects as they build on their partnership
Dr. Reddy’s Stakes Claim In U.S. OTC Market With Leiner Deal
Dr. Reddy's Laboratories' foothold in the U.S. OTC drug market appears ready for expansion after the firm signed an exclusive 15-year OTC product development and marketing agreement with Leiner Health Products
Famotidine, permethrin lotion ANDAs
Genpharm receives FDA clearance for famotidine 10 mg tablets (ANDA 75-674) Dec. 21, becoming fourth firm to gain approval for private label stomach remedy equivalent to J&J/Merck's Pepcid AC (1"The Tan Sheet" Aug. 27, 2001, In Brief). Clay-Park Labs' Permethrin Lotion 1% (ANDA 76-090) receives FDA approval Dec. 20 and is second generic version of Pfizer/Warner-Lambert's Nix pediculicide...